Advanced molecular imaging in large-vessel vasculitis: Adopting FDG-PET into a clinical workflow

Best Pract Res Clin Rheumatol. 2023 Mar;37(1):101856. doi: 10.1016/j.berh.2023.101856. Epub 2023 Jul 27.

Abstract

The use of fluorodeoxyglucose-positron emission tomography (FDG-PET) imaging to detect vascular inflammation is increasingly common in the clinical management of patients with large-vessel vasculitis (LVV). In this review, the role of FDG-PET imaging to diagnose and monitor vascular disease activity will be detailed. Suggestions on incorporation of FDG-PET imaging into a clinical workflow will be provided with emphasis on patient preparation, image acquisition, and image interpretation. If FDG-PET imaging is obtained, multimodal imaging assessment, whereby FDG-PET imaging and non-invasive angiography are obtained concurrently, and correlation of imaging findings with clinical assessment is generally advisable. Considering the clinical scenario and treatment status of the patient is important when interpreting vascular FDG-PET image findings.

Keywords: Fluorodeoxyglucose; Giant cell arteritis; Imaging; Large-vessel vasculitis; PET-CT; Takayasu's arteritis.

Publication types

  • Review

MeSH terms

  • Fluorodeoxyglucose F18
  • Giant Cell Arteritis*
  • Humans
  • Molecular Imaging
  • Positron Emission Tomography Computed Tomography
  • Positron-Emission Tomography / methods
  • Vasculitis* / diagnostic imaging
  • Workflow

Substances

  • Fluorodeoxyglucose F18